We are live on ! Find out more
GF

Gates Foundation Portfolio holdings

AUM $43.5M
1-Year Est. Return 14.19%
This Fund
S&P 500
This Quarter Est. Return
+15.62%
1 Year Est. Return
+14.19%
3 Year Est. Return
-58.08%
5 Year Est. Return
10 Year Est. Return
AUM
$89.9M
AUM Growth
+$6.01M
Cap. Flow
-$17.5K
Cap. Flow %
-0.02%
Top 10 Hldgs %
100%
Holding
9
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
AMRS
Amyris Inc.
AMRS
+$17.5K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMCR icon
1
Immunocore
IMCR
$1.78B
$39.4M 43.85%
576,923
BNTX icon
2
BioNTech
BNTX
$22.7B
$15.7M 17.46%
148,674
VIR icon
3
Vir Biotechnology
VIR
$1.48B
$15.7M 17.45%
1,559,142
EXAI
4
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$10.2M 11.35%
1,590,909
CVAC
5
DELISTED
CureVac
CVAC
$6.83M 7.6%
1,625,943
BFLY icon
6
Butterfly Network
BFLY
$1.73B
$1.09M 1.21%
1,011,003
LMDX
7
DELISTED
LumiraDx Limited Common Shares
LMDX
$857K 0.95%
14,285,714
BCEL
8
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$119K 0.13%
912,642
AMRS
9
DELISTED
Amyris Inc.
AMRS
-292,398
Closed -$17.5K

Similar funds

Gates Foundation's Q4 2023 Portfolio in Review

As of Q4 2023, Gates Foundation held 9 positions worth $89.9M, up 7.2% from $83.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Gates Foundation's Q4 2023 filing shows 1 closed position. The largest sale was Amyris Inc., an estimated $17.5K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier, followed by Materials.

  • Gates Foundation fully exited Amyris Inc. in Q4 2023, selling an estimated $17.5K.
  • Gates Foundation's ten largest holdings make up 100% of its $89.9M portfolio in Q4 2023.
  • Gates Foundation opened 0 new positions and closed 1 in Q4 2023.
  • Gates Foundation's portfolio value rose 7.2% quarter-over-quarter to $89.9M.

Based on Gates Foundation's 13F filing for Q4 2023, filed 14 Feb 2024.